These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15474016)

  • 1. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.
    Wang YY; Li L; Han KJ; Zhai Z; Shu HB
    FEBS Lett; 2004 Oct; 576(1-2):86-90. PubMed ID: 15474016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis.
    Zhang J; Xu LG; Han KJ; Wei X; Shu HB
    FEBS Lett; 2004 Jul; 570(1-3):97-101. PubMed ID: 15251447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
    Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
    J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.
    Huang J; Liu T; Xu LG; Chen D; Zhai Z; Shu HB
    EMBO J; 2005 Dec; 24(23):4018-28. PubMed ID: 16281057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.
    Aksoy E; Vanden Berghe W; Detienne S; Amraoui Z; Fitzgerald KA; Haegeman G; Goldman M; Willems F
    Eur J Immunol; 2005 Jul; 35(7):2200-9. PubMed ID: 15940673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
    Lin R; Yang L; Nakhaei P; Sun Q; Sharif-Askari E; Julkunen I; Hiscott J
    J Biol Chem; 2006 Jan; 281(4):2095-103. PubMed ID: 16306043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.
    Han KJ; Su X; Xu LG; Bin LH; Zhang J; Shu HB
    J Biol Chem; 2004 Apr; 279(15):15652-61. PubMed ID: 14739303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A20 is a negative regulator of IFN regulatory factor 3 signaling.
    Saitoh T; Yamamoto M; Miyagishi M; Taira K; Nakanishi M; Fujita T; Akira S; Yamamoto N; Yamaoka S
    J Immunol; 2005 Feb; 174(3):1507-12. PubMed ID: 15661910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.
    Oshiumi H; Sasai M; Shida K; Fujita T; Matsumoto M; Seya T
    J Biol Chem; 2003 Dec; 278(50):49751-62. PubMed ID: 14519765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells.
    Osterlund P; Veckman V; Sirén J; Klucher KM; Hiscott J; Matikainen S; Julkunen I
    J Virol; 2005 Aug; 79(15):9608-17. PubMed ID: 16014923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3.
    Elco CP; Guenther JM; Williams BR; Sen GC
    J Virol; 2005 Apr; 79(7):3920-9. PubMed ID: 15767394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple NF-kappaB and IFN regulatory factor family transcription factors regulate CCL19 gene expression in human monocyte-derived dendritic cells.
    Pietilä TE; Veckman V; Lehtonen A; Lin R; Hiscott J; Julkunen I
    J Immunol; 2007 Jan; 178(1):253-61. PubMed ID: 17182562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
    Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
    Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a TIR-less splice variant of TRIF reveals an unexpected mechanism of TLR3-mediated signaling.
    Han KJ; Yang Y; Xu LG; Shu HB
    J Biol Chem; 2010 Apr; 285(17):12543-50. PubMed ID: 20200155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells.
    Gon Y; Asai Y; Hashimoto S; Mizumura K; Jibiki I; Machino T; Ra C; Horie T
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):330-6. PubMed ID: 15142865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of lipopolysaccharide-induced interferon-β production by 2-aminopurine.
    Sugiyama T; Gotou T; Moriyama K; Kajiura N; Hasegawa T; Tomida J; Takahashi K; Komatsu T; Ueda H; Sato K; Tokoro S; Neri P; Mori H
    Mol Immunol; 2012 Oct; 52(3-4):299-304. PubMed ID: 22750230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
    Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
    J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.